Authors
Latest:
Advancing CML Management Towards an Ideal Patient JourneyThe panel concludes its discussion with insights on challenges and unmet needs in the CML treatment landscape, highlighting ways to better support patients and caregivers.
Latest:
Wheatley and Gopalsami Highlight the Value of Interdisciplinary Collaboration in HSCT CareTia Wheatley, DNP, RN, AOCNS, BMTCN, and Shivani Gopalsami, RN, MSN, ANP-BC, AOCNP, discuss the benefits and challenges of multidisciplinary collaboration in hematopoietic stem cell transplant care.
Latest:
Caring for an Immunocompromised Bone Marrow Transplant RecipientSpecial protocols are required to ensure the safety of patients undergoing bone marrow transplants.
Latest:
Cancer Care Advancements in 2024 and BeyondThis past year, the role of ctDNA testing has expanded to guide treatment decisions for providers and patients with cancer.
Latest:
Empower Your Clinical Staff to Meet the Growing Patient VolumeOncology practices can create more access to care by leveraging the use of APPs, empowering nurses to practice at the top of their licensure, utilizing nurse navigators, and planning ahead.
Latest:
Oncology Rapid Access Clinics: APPs Improve Outcomes for Acutely Ill PatientsOncology rapid-access clinics should be essential to patient care standards across the oncology continuum.
Latest:
Unlocking Bladder Cancer: A Guide to Effective Diagnosis and StagingExperts share insights on standard work-up and staging practices for a patient with newly diagnosed bladder cancer.
Latest:
Older Patients Are Comfortable With Telehealth and Prefer It as an Option92% of those over 70 say they are comfortable with telehealth.
Latest:
Insights on Evolving Treatment Strategies for Multiple MyelomaThe panel provides key takeaways on the most impactful innovations shaping the future of multiple myeloma treatment.
Latest:
Key Takeaways for Patients With MyelofibrosisPatients with myelofibrosis should reflect on their personal priorities and quality of life goals, understand the range of available JAK inhibitor treatment options, and openly communicate with their doctor to arrive at a shared decision for managing their disease.
Latest:
Heather Niccum Haag on Improving Patient Education With BelzutifanHeather Niccum Haag, BSN, RN, CCRN, shares her experience creating an educational resource for her patients with Von-Hippel Lindau tumors who are receiving belzutifan.
Latest:
Neoadjuvant ICIs May Improve Efficacy Outcomes in Early-Stage TNBCNeoadjuvant immune checkpoint inhibitors plus chemotherapy also improved efficacy outcomes in PD-L1-positive/ERBB2-negative tumors.
Latest:
Advanced Practice Providers Are Uniquely Suited for Survivorship CareAdvanced practice providers are the future of survivorship care because of the tremendous value they offer to the practice and its patients.
Latest:
Study Supports Role of ctDNA in Predicting Outcomes in HR+ Early Breast CancerBaseline ctDNA presence was associated with larger tumor size and higher residual disease burden scores following neoadjuvant endocrine therapy in HR-positive, early breast cancer.
Latest:
Global Study Suggests More Informational Resources Needed for Renal Cell CarcinomaA global study revealed that patients and caregivers alike reported insufficient knowledge surrounding renal cell carcinoma.
Latest:
Caring for a Patient Undergoing CAR T-Cell Therapy for Relapsed/Refractory Multiple MyelomaThe introduction of CAR T-cell therapy for patients with relapsed/refractory multiple myeloma is considered one of the most significant advancements in the past decade.
Latest:
Prescribing 20 mg of Mozart for Chemotherapy-Induced NauseaA Michigan State University investigator is preparing to expand on an encouraging pilot study that used a music-listening intervention to influence chemotherapy-induced nausea.
Latest:
5 Media Tips and Tricks For Health Care ProfessionalsHeather Simonsen, MA, outlines some ways for health care professionals to feel more comfortable in the spotlight.
Latest:
Oncology Drug Crash Course: Teclistamab-cqyv (Tecvayli)Amanda Warner, MS, BSN, RN, OCN, who is manager of research informatics & real world evidence with Florida Cancer Specialists & Research Institute, provides an in-depth look at teclistamab in a downloadable fact sheet.
Latest:
Datopotamab Deruxtecan Demonstrates Manageable Safety Profile in TNBCCompared with other antibody-drug conjugates, datopotamab deruxtecan was associated with lower rates of neutropenia, pneumonitis, and hematologic toxicity.
Latest:
Rx Road Map: Adagrasib (Krazati)Dawn Landolph, RN, BSN, OCN, MPA, provides an in-depth look at adagrasib for the treatment of patients with KRAS G12C-mutated, locally advanced or metastatic non-small cell lung cancer in a downloadable reference sheet.
Latest:
Talking With Patients About Potential Cancer MisinformationOncology nurses can help their patients navigate misinformation that they may find online.
Latest:
Top Executives Vow to Improve Health Disparities among Patients with Multiple MyelomaOncology nurses are often the main point of contact for newly diagnosed patients with cancer. We have the opportunity to ensure that each person starts their journey with equality and equity on their side.
Latest:
Rx Road Map: Amivantamab (Rybrevant) Plus Lazertinib (Lazcluze)APPs provide an in-depth look at amivantamab plus lazertinib for the treatment of patients with locally advanced or metastatic non–small cell lung cancer.
Latest:
Chemotherapy Plus Endocrine Therapy Increases Cognitive Impairment in Breast CancerPatients with breast cancer may be at risk for more intense cognitive impairment following treatment with chemotherapy plus endocrine therapy.
Latest:
Hilda Haynes-Lewis and Rosaleen Bloom on Financial Toxicity and Workplace Stressors for Patients Undergoing RadiationHilda Haynes-Lewis, PhD, ANP-BC, AOCNP; and Rosaleen Bloom PhD, APRN, ACNS-BC, AOCNS, discuss the ways a cancer diagnosis can impair an individual’s ability to work normally.
Latest:
Study suggests Lymphoma Patients With Depression or Anxiety Experience Shorter Survival TimesPatients with depression had a 37% higher risk of dying from their disease than patients without a mental health diagnosis.
Latest:
Unmet Needs and Future Perspectives on the treatment of R/R MMExperts provide advice for patients and caregivers with relapsed/refractory multiple myeloma considering talquetamab or another bispecific, while all faculty will discuss unmet needs and future perspectives in the treatment of relapsed/refractory multiple myeloma.
